MD-920 Ophthalmic Laser

MEDA Co., Ltd.

Tianjin, China

Founded in 2004 with a registered capital of RMB53 million, MEDA Co., Ltd. (MEDA) is now based in Xinmao Science Skill Park, Huayuan Industry Development Area, Tianjin Binhai Hi-Tech Industrial Development Area. In 2013, MEDA went public with a listing on the National Equities Exchange and Quotations (NEEQ: 430220). By growing in the direction of professional medical devices on basis of ophthalmic clinical applications and driving corporate and academic innovations in ultrasound, laser and optics, MEDA is well-positioned in breaking international monopolies with its home-grown, sophisticated, ever-improving products. By leveraging its leading technologies on ophthalmology, dermatology, urology and ENT, it has developed a line of edge-cutting professional medical products to address market needs, take the lead in international competitions, build the national brand and drive the continuous growth of the company. Among its products for diagnosis and treatment in ophthalmic ultrasound, laser and optics as well in urology, dermatology and ENT, MEDA has obtained CE certification and got FDA clearance for its products for ophthalmic ultrasound and urology. MEDA has also won dozens of awards, such as the second prize of National Science and Technology Progress Award, the first prize of Tianjin Science and Technology Progress Award and the second and third prizes of Ministry of Health and Tianjin Science and Technology Progress. MEDA has promoted these products to over 7,000 hospitals across China, including nearly 3,000 grade-A tertiary and secondary hospitals, as a replacement for like products from aboard, and also expanded its presence across more than 60 countries and regions.